摘要
酸性成纤维生长因子-1(FGF-1)由于氨基端缺乏信号肽序列,不能通过经典的内质网-高尔基体途径释放。但在一些应激条件下,FGF-1与S100A13,P40syt1,SK1结合成多蛋白释放复合体,实现跨磷脂膜的出胞转运。FGF-1与许多病理过程有关,因而一些干预FGF-1释放途径的措施为治疗FGF-1介导的疾病提供了新的思路。
Fibroblast growth factor( FGF-1 )lacks amino-terminal signal peptide, so it can't release through the classical endoplasmic reticulum (ER)-Golgi pathway. Under some stresses, FGF-1 binds S00A13 ,P40Sytl, and SK1 to be a muhiprotein release complex that is released into extracellular compartment across membrane. FGF-1 is involved in many pathological processes, so the measures to disturb or inhibit FGF-1 release pathway provide a new strategy for the diseases directed by FGF-1.
出处
《国际病理科学与临床杂志》
CAS
2008年第6期540-543,共4页
Journal of International Pathology and Clinical Medicine
基金
湖南省自然科学基金(06JJ50046)~~